One stock that's trending within range of triggering a major breakout trade is Anacor Pharmaceuticals (ANAC - Get Report), a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. This stock has been hammered by the bears so far in 2013, with shares off by 25%.
This company reported earnings on Thursday, beating Wall Street EPS estimates by 9 cents per share, after reporting a loss of 36 cents per share versus estimates of a loss of 44 cents per share. Revenue rose 26.15% to $3.28 million from the year-earlier period.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts